Samsung Biologics, Foreigners Net Sell 10,141 Shares... Stock Price -2.1%

Samsung Biologics ranked among the top searched stocks for 14 days in the past month.

As of 2:31 PM on the 29th, Samsung Biologics is trading at 793,000 KRW, down 2.1% from the previous day. This represents a 26.68% increase compared to June 3. Samsung Biologics is known as the holding company for Samsung Group's bio business.

Today, foreigners have a net sell of 10,141 shares of Samsung Biologics, while institutions have a net buy of 4,000 shares, according to provisional data. Over the past five days, individual investors have net bought 17,886 shares, while foreigners and institutions have net sold 55,166 shares and net bought 27,948 shares, respectively.

On June 24, Samsung Biologics was a market highlight for its "strong performance following a 380 billion KRW contract signing."

[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.